AQR CAPITAL MANAGEMENT LLC
Position in XERS — Xeris Biopharma Holdings, Inc.
CIK 1167557
Greenwich, CT
Position in XERS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$12,204,598
+$4,117,221 QoQ
Shares Held
1,540,985
+10.5% QoQ
Ownership
0.845%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 238 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in XERS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $1,405,033,456 across 42 Drug Manufacturers - Specialty & Generic names. XERS ranks #12 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
3,818,037 | $643,491,951 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
546,002 | $295,840,259 | |
| 3 | ZTS |
Zoetis Inc.
|
1,070,929 | $76,956,955 | |
| 4 | VTRS |
Viatris Inc
|
4,694,966 | $74,556,056 | |
| 5 | PRGO |
PERRIGO Co plc
|
3,480,666 | $36,164,117 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
261,250 | $28,983,071 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
6,465,921 | $27,221,524 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
1,525,686 | $24,456,745 |
All Filings in XERS
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,204,598 | 1,540,985 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $8,087,377 | 1,394,376 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $7,516,992 | 957,579 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $8,006,502 | 983,600 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $4,898,796 | 1,048,993 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $5,197,743 | 946,766 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $2,830,446 | 834,940 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,044,129 | 1,068,116 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,684,430 | 1,193,080 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,521,621 | 1,141,006 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $642,071 | 273,222 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $78,640 | 42,280 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $35,810 | 13,668 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $51,452 | 31,566 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $66,837 | 50,254 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $32,045 | 20,542 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||